News Article
Riber revenues rescued by research lab sales
The company says the €27.4 million in revenues for 2012 were in line with objectives
MBE system manufacturer Riber has reported €27.4 million in revenues for 2012, driven by system sales to research laboratories.
Revenues for the fourth quarter of 2012 came to €10.7 million, compared with €10.5 million for the fourth quarter of 2011.
In 2012, the decline in sales of cells and sources was offset by the growth in MBE activity.
During 2012, Riber invoiced and delivered 17 MBE machines compared with 10 in 2011. With 15 systems in 2012, deliveries to research laboratories climbed to an all-time high.
Sales of services and accessories, supported by a commercial recovery plan launched at the end of 2011, were up by 9 percent. This confirmed an upturn in business during the second half of the year.
However, sales of evaporation sources and cells declined due to low investments for OLED production.
On December 31st, 2012, the breakdown of Riber's revenues in terms of percentage are shown below.
Outlook
During the last quarter of 2012, Riber recorded orders for three systems for research laboratories in the US and Austria.
On December 31st, 2012, the order book represented €12.1 million (€19.4 million one year earlier). It includes 11 MBE research systems to be delivered in 2013.
The services and accessories business has continued to see a positive trend, with Riber's order book coming in 21 percent higher than the previous year.
2012 full-year earnings will be released on April 4th, 2013 (before start of trading).
Revenues for the fourth quarter of 2012 came to €10.7 million, compared with €10.5 million for the fourth quarter of 2011.
In 2012, the decline in sales of cells and sources was offset by the growth in MBE activity.
During 2012, Riber invoiced and delivered 17 MBE machines compared with 10 in 2011. With 15 systems in 2012, deliveries to research laboratories climbed to an all-time high.
Sales of services and accessories, supported by a commercial recovery plan launched at the end of 2011, were up by 9 percent. This confirmed an upturn in business during the second half of the year.
However, sales of evaporation sources and cells declined due to low investments for OLED production.
On December 31st, 2012, the breakdown of Riber's revenues in terms of percentage are shown below.
Outlook
During the last quarter of 2012, Riber recorded orders for three systems for research laboratories in the US and Austria.
On December 31st, 2012, the order book represented €12.1 million (€19.4 million one year earlier). It includes 11 MBE research systems to be delivered in 2013.
The services and accessories business has continued to see a positive trend, with Riber's order book coming in 21 percent higher than the previous year.
2012 full-year earnings will be released on April 4th, 2013 (before start of trading).
